Corient Private Wealth
JBIO

Corient Private Wealth’s Jade Biosciences JBIO Stock Holding History

Corient Private Wealth’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37M Buy
+61,530
New +$1.28M ﹤0.01% 1613
2025
Q4 		– Sell
-11,741
Closed -$101K – 2653
2025
Q3 		$101K Buy
11,741
+1,608
+16% +$13.1K ﹤0.01% 2443
2025
Q2 		$101K Buy
+10,133
New +$345K ﹤0.01% 2329
2025
Q1 		– Sell
-1,054
Closed -$97.8K – 2292
2024
Q4 		$97.8K Buy
+1,054
New +$90.8K ﹤0.01% 2227

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Corient Private Wealth's JBIO Position: Q2 2026 in Review

Corient Private Wealth opened a new position in Jade Biosciences (JBIO) in Q2 2026: 61,530 shares worth $1.37M. The stake represents ﹤0.01% of the portfolio and ranks #1613 among its holdings. This is a return to the name: Corient Private Wealth previously reported a position in JBIO as recently as Q3 2025.

Corient Private Wealth first reported a position in JBIO in Q4 2024 and has held it in 4 quarters since. 153 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Corient Private Wealth held 61,530 shares of Jade Biosciences worth $1.37M as of Q2 2026.
  • Jade Biosciences was a new Corient Private Wealth position in Q2 2026.
  • Jade Biosciences made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1613 holding.
  • Corient Private Wealth first reported a position in Jade Biosciences in Q4 2024 and has held it in 4 quarters since.
  • 153 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.